Pfizer's Q3: Profit Boosted by Cost Cuts Amidst Major Obesity Acquisition Battle

Pfizer announced strong third-quarter profits, allowing it to raise its 2025 profit forecast. This improvement relies on major cost-cutting efforts, even as the company faces fierce competition and a high-stakes legal fight over the obesity startup Metsera.